Opinion|Videos|March 21, 2024
Challenges in Treating High-Risk Patients With Diabetes
Estay Greene, PharmD, MBA, outlines the main barriers that need to be addressed from a payer perspective in the treatment of high-risk patients with diabetes.
Advertisement
Episodes in this series
Advertisement
Related to this article
In the CONNECT trial, CGM users with type 2 diabetes not on insulin saw larger A1C reductions and more time in range than those using finger-stick testing.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
CVS Health is splitting in two, according to news reports
2
Jeremy Gaskill on moving from Humana to Geisinger Health Plan
3
The CVS Health split. How separate will the two companies really be?
4
A Democratic Congress likely means more oversight for payers, not a Medicaid rollback
5